Tracking ABUS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AB
Arbutus Biopharma Corporation (ABUS) short interest & options flow
NASDAQLatest pulse2 Oct 2026
ABUS cost to borrow surges to 8.6%, up 1,425% in one week as borrow market seizes.
$3.88+1.57% 1d-4.43% 1w-8.06% 1mClose: 11 Nov 2026
- Market cap
- $595M
- Next earnings
- 12 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 12 Nov 2026
Latest signals on ABUS
- Cost to Borrow
ABUS cost to borrow surges to 8.6%, up 1,425% in one week as borrow market seizes.
- Short Interest
ABUS short interest surged 34% in one week to 13.5% of free float, while cost to borrow exploded to 8.6%, up from near-zero a month ago.
ABUS news and analysis
RSSNo long-form analysis yet for ABUS. Pulse alerts and the live data picture are available on ORTEX.
Open ABUS on ORTEX →Want the live picture for ABUS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABUS — free to start on ORTEX.
Sign up for free →Open ABUS on ORTEX